239: The Four Steps Pathology AI Demos Quietly Skip and Why They Matter

Send us Fan MailWhat happens when a pathology AI model misses the tissue before it even begins—and can better segmentation, education, and virtual staining close the gaps?In DigiPath Digest #47, I review four recent studies that expose both the promise and the weak points of AI-assisted digital pathology. We start with a step that sounds simple: detecting tissue on a whole slide image. Yet when that first step fails, the downstream algorithm may miss cancer entirely.From there, I look at a practical resource designed to improve communication between pathologists and computational scientists, a self-refining Segment Anything Model that reduces the burden of pixel-perfect nuclear annotations, and a virtual HER2 immunohistochemistry method generated from H&E images.The common lesson? Digital pathology AI is only as reliable as the workflow underneath it. Tissue processing, scanning, segmentation, annotation, model design, and clinical interpretation all matter. Every step needs validation.Discussion highlights00:00 – Welcome to DigiPath Digest #47 and an overview of the four papers02:31 – Why tissue detection is the foundation of pathology AI workflows05:01 – A large prostate pathology study using 33,823 whole slide images for tissue detection and 70,000 images for downstream Gleason grading06:28 – Classical thresholding missed tissue completely on 118 slides, compared with 24 slides using U-Net++ tissue detection07:51 – How artifacts and uneven slide color can disrupt classical detection methods09:59 – AI-based tissue detection reduced total failures by 79% but didn’t eliminate them10:39 – Why validating only the final algorithm output can hide upstream sources of error12:05 – Tissue detection choice produced clinically significant differences in final Gleason grade in 3.5% of malignant slides13:33 – The communication gap between pathology and computer science—and why it still slows progress15:29 – “Decoding Digital Histopathology” as an accessible guide for computational researchers entering pathology18:03 – Digital Pathology 101, my free companion resource for anyone starting or continuing a digital pathology journey20:18 – From collected tissue to glass slide, whole slide image, interpretation, and computational analysis25:08 – The role of TCGA and the growth of digital pathology datasets across clinical, veterinary, preclinical, and research settings27:14 – Why pixel-level nuclear annotation remains a bottleneck for deep learning30:39 – Replacing detailed nuclear outlines with simple point prompts31:23 – How the self-refining SAM framework uses sparse labels, contrastive learning, and a correction loop33:25 – Do we really need to keep annotating the same structures for every new model?37:49 – Generating virtual HER2 IHC from H&E with a score-aware, non-contrastive multitask model39:53 – Study results: 83.01% accuracy for virtual IHC alone and 97.85% accuracy when H&E and virtual IHC were combined40:56 – Where virtual IHC may fit as a complementary or triage tool—and why confirmatory testing still matters44:06 – My perspective on trust, interpretation, and the difference between predicting IHC and predicting molecular alterations46:17 – Final thoughts and an invitation to continue the discussionResources mentioned“Impact of Tissue Detection on Diagnostic Artificial Intelligence Algorithms in Prostate Digital Pathology” – Scientific Reports“Decoding Digital Histopathology: The Building Blocks for Computational Researchers” – PLOS Digital Health“Self-Refining Segment Anything Model for Nuclear Segmentation: A Contrastive Learning Approach to Label-Efficient Pathological Imaging” – Diagnostics“HER2 Score-Aware Virtual Immunohistochemistry via Non-Contrastive Multitask Translation” – DiagnosticsDigital Pathology 101: All You Need to Know to Start and Continue Your Digital Pathology JourneyEuropean Society of Digital and Integrative PathologyThe Cancer Genome Atlas (TCGA)If you work in pathology, computational science, image analysis, or AI development, this episode is a useful reminder to look beyond the headline performance metric. The errors that matter may begin much earlier in the workflow.Support the showGet the "Digital Pathology 101" FREE E-book and join us!